IDEX Biometrics ASA
IDEX.OL · OSL
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | NOK 0 | NOK 81 | NOK 104 | NOK 24 |
| % Growth | -100% | -22.1% | 333.3% | – |
| Cost of Goods Sold | NOK 1,333 | NOK 57 | NOK 86 | -NOK 118 |
| Gross Profit | -NOK 1,333 | NOK 24 | NOK 18 | NOK 142 |
| % Margin | – | 29.6% | 17.3% | 591.7% |
| R&D Expenses | NOK 3,544 | NOK 532 | NOK 545 | -NOK 223 |
| G&A Expenses | NOK 0 | NOK 0 | NOK 0 | NOK 0 |
| SG&A Expenses | NOK 15,125 | NOK 6,843 | NOK 0 | NOK 0 |
| Sales & Mktg Exp. | NOK 0 | NOK 0 | NOK 0 | NOK 0 |
| Other Operating Expenses | NOK 0 | -NOK 4,306 | NOK 2,587 | NOK 4,681 |
| Operating Expenses | NOK 18,669 | NOK 3,069 | NOK 3,132 | NOK 4,458 |
| Operating Income | -NOK 1,983 | -NOK 3,045 | -NOK 3,114 | -NOK 4,316 |
| % Margin | – | -3,759.3% | -2,994.2% | -17,983.3% |
| Other Income/Exp. Net | NOK 991 | NOK 931 | -NOK 1,028 | NOK 2,074 |
| Pre-Tax Income | -NOK 992 | -NOK 2,114 | -NOK 4,142 | -NOK 2,242 |
| Tax Expense | NOK 0 | -NOK 43 | NOK 2 | -NOK 122 |
| Net Income | -NOK 992 | -NOK 2,070 | -NOK 4,144 | -NOK 2,119 |
| % Margin | – | -2,555.6% | -3,984.6% | -8,829.2% |
| EPS | -0.24 | -7 | -0.005 | -0.007 |
| % Growth | 96.6% | -142,757.1% | 30.4% | – |
| EPS Diluted | -0.24 | -7 | -0.005 | -0.007 |
| Weighted Avg Shares Out | 42,109 | 299 | 831,628 | 527,959 |
| Weighted Avg Shares Out Dil | 42,109 | 299 | 831,578 | 528,409 |
| Supplemental Information | – | – | – | – |
| Interest Income | NOK 8 | NOK 998 | NOK 7 | NOK 57 |
| Interest Expense | NOK 253 | NOK 67 | NOK 263 | NOK 249 |
| Depreciation & Amortization | NOK 1,333 | NOK 140 | NOK 138 | NOK 1,255 |
| EBITDA | -NOK 6,099 | -NOK 1,907 | -NOK 3,741 | -NOK 738 |
| % Margin | – | -2,354.3% | -3,597.1% | -3,075% |